LIPOTOX
LIPOTOX
Discontinued
DIN Number
02233643
Drug Class
Human
Market Date
May 26, 1998
Company
HC
bio active canada ltd.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02233643
AIG Number1132231001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification
ACTIVE INGREDIENTS (11)
BORAGO OFFICINALISActive
Strength: 3 X
Monograph: BORAGO OFFICINALIS
CAPSICUMActive
Strength: 12 X
Monograph: CAPSICUM
CHOLESTEROLActive
Strength: 12 X
Monograph: CHOLESTEROL
GRAPHITEActive
Strength: 12 X
Monograph: GRAPHITE
IRONActive
Strength: 12 X
Monograph: IRON
LYCOPODIUM CLAVATUMActive
Strength: 30 X
Monograph: LYCOPODIUM CLAVATUM
OYSTER SHELLSActive
Strength: 12 X
Monograph: OYSTER SHELLS
PHOSPHORIC ACIDActive
Strength: 30 X
Monograph: PHOSPHORIC ACID
PHOSPHORUSActive
Strength: 30 X
Monograph: PHOSPHORUS
RICINUS COMMUNISActive
Strength: 12 X
Monograph: RICINUS COMMUNIS
SEPIA OFFICINALIS LActive
Strength: 12 X
Monograph: SEPIA OFFICINALIS L